ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 682,34
-0,54%
Dow Jones
40 211,72
0,53%
DAX
18 590,89
-0,95%
Brent Oil
84,135
-0,24%
Bitcoin
64 683,30
-0,26%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
07/04/202014h00PR Newswire (US)Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid ...NASDAQ:PTLAPortola Pharmaceuticals Inc
01/04/202022h02PR Newswire (US)Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:PTLAPortola Pharmaceuticals Inc
18/03/202021h11PR Newswire (US)Portola Pharmaceuticals Announces Proactive Steps Supporting Public Health Efforts to Combat Coronavirus (COVID-19)NASDAQ:PTLAPortola Pharmaceuticals Inc
16/03/202013h05PR Newswire (US)Portola Pharmaceuticals Announces Results Demonstrating Andexxa® was Associated with Lowest Rate of Mortality in Patients wi...NASDAQ:PTLAPortola Pharmaceuticals Inc
05/03/202014h30PR Newswire (US)New Data Demonstrates Andexxa® Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with...NASDAQ:PTLAPortola Pharmaceuticals Inc
04/03/202000h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
03/03/202021h59Business WireShareholder Alert: Robbins LLP Announces Another Complaint Filed Against Portola Pharmaceuticals, Inc. (PTLA)NASDAQ:PTLAPortola Pharmaceuticals Inc
02/03/202017h27Business WireFederman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Portola ...NASDAQ:PTLAPortola Pharmaceuticals Inc
28/02/202022h12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
28/02/202001h52Business WirePTLA INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors in Portola Pharmaceuticals, Inc. of a Filing Deadline in ...NASDAQ:PTLAPortola Pharmaceuticals Inc
26/02/202022h24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
26/02/202022h01PR Newswire (US)Portola Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
24/02/202014h00PR Newswire (US)Portola Pharmaceuticals to Participate in Two Upcoming Investor ConferencesNASDAQ:PTLAPortola Pharmaceuticals Inc
14/02/202015h54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
12/02/202014h00PR Newswire (US)Portola Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020NASDAQ:PTLAPortola Pharmaceuticals Inc
12/02/202000h28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PTLAPortola Pharmaceuticals Inc
10/02/202021h42Business WireShareholder Alert: Robbins LLP Reminds Investors Portola Pharmaceuticals, Inc. (PTLA) Sued for Misleading ShareholdersNASDAQ:PTLAPortola Pharmaceuticals Inc
10/02/202018h03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTLAPortola Pharmaceuticals Inc
08/02/202000h00GlobeNewswire Inc.Saxena White P.A. Files New Securities Fraud Class Action Complaint Against Portola Pharmaceuticals, Inc. with Expanded Class...NASDAQ:PTLAPortola Pharmaceuticals Inc
03/02/202017h15PR Newswire (US)WeissLaw LLP: Portola Pharmaceuticals, Inc. is the Subject of a Legal InvestigationNASDAQ:PTLAPortola Pharmaceuticals Inc
03/02/202014h30PR Newswire (US)Portola Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President and Chief Medical OfficerNASDAQ:PTLAPortola Pharmaceuticals Inc
30/01/202015h00Business WireThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Portola Pharmaceut...NASDAQ:PTLAPortola Pharmaceuticals Inc
27/01/202019h46PR Newswire (US)PTLA LOSSES ALERT: Bernstein Liebhard LLP Reminds Investors of its Investigation into Portola Pharmaceuticals, Inc., and Enco...NASDAQ:PTLAPortola Pharmaceuticals Inc
21/01/202021h51Business WireShareholder Alert: Robbins LLP Announces Portola Pharmaceuticals, Inc. (PTLA) Sued for Misleading ShareholdersNASDAQ:PTLAPortola Pharmaceuticals Inc
18/01/202001h17Business WirePTLA LOSSES ALERT: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Portola Pharmaceuticals, ...NASDAQ:PTLAPortola Pharmaceuticals Inc
17/01/202022h01Business WireThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Portola Pharmaceuticals, Inc....NASDAQ:PTLAPortola Pharmaceuticals Inc
11/01/202000h41Business WireThe Law Offices of Frank R. Cruz Announces Investigation on Behalf of Portola Pharmaceuticals, Inc., (PTLA)NASDAQ:PTLAPortola Pharmaceuticals Inc
10/01/202018h04PR Newswire (US)(PTLA) Alert: Johnson Fistel Launches Investigation into Portola Pharmaceuticals; Investors Encouraged to Contact FirmNASDAQ:PTLAPortola Pharmaceuticals Inc
09/01/202022h01PR Newswire (US)Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 MillionNASDAQ:PTLAPortola Pharmaceuticals Inc
08/01/202020h03Edgar (US Regulatory)Schedule 13gNASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

BIT
P24U36
NLBNPIT24U36 20250321 8
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés